People: Eagle Pharmaceuticals Inc (EGRX.OQ)
21 Aug 2019
Mr. David M. Pernock is President, Chief Operating Officer of the Company. Previously, Mr. Pernock served as a member of our Board from April 2015 until January 2017. Before becoming our President and Chief Commercial Officer in January 2017, Mr. Pernock served as chairman of the board of directors since September 2009 and as chief executive officer since February 2010 of Fibrocell Science, Inc., a publicly-traded autologous cell and gene therapy company. From December 1993 until November 2009, Mr. Pernock held various positions at GlaxoSmithKline, eventually serving as senior vice president of pharmaceuticals, vaccines (biologics), oncology, acute care, and HIV divisions. From May 2009 until February 2011, Mr. Pernock served as a director of Martek Biosciences Corporation. Mr. Pernock holds a B.S. in business administration from Arizona State University.
|Total Annual Compensation, USD||540,653|
|Restricted Stock Award, USD||1,493,300|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,641,490|
|Fiscal Year Total, USD||3,675,440|